oncotarget: phenotypic changes in her2 breast cancer
Published 3 years ago • 98 plays • Length 0:53Download video MP4
Download video MP3
Similar videos
-
1:40
continuous abemaciclib treatment leads to breast cancer inhibition | oncotarget
-
4:56
oncotarget: linc00520 is induced by src, stat3, and pi3k in breast cancer
-
4:54
oncotarget: osteoprotegerin rich tumor microenvironment: implications in breast cancer
-
12:54
oncotarget: onc201 kills breast cancer cells in vitro by targeting mitochondria
-
0:39
learn how quercetin, found in everyday foods help in modulating her2 protein in breast cancer #her2
-
0:39
exploring the science of il8 cytokine activation in her2 positive breast cancer #il8 #her2
-
3:09
her2 in cancer
-
1:29:07
2021 sabcs what changes monday morning? her2 breast cancer panel discussion
-
1:02:48
expanding treatment options in er /her2- breast cancer: serds, serms, sercas, and more
-
0:31
get to know her2-positive breast cancer and its targeted treatments
-
7:24
oncotarget: researchers identify potential therapeutic target in aggressive breast cancer cells
-
55:51
her2 testing in breast cancer: improving ihc performance
-
0:34
helping to address unmet needs in metastatic hr /her2- breast cancer
-
54:02
navigating shifts in the treatment landscape for metastatic her2-positive breast cancer
-
1:09:24
raising the bar in hr /her2- early breast cancer: cdk4 and 6 inhibitors
-
6:29
study of palbociclib after cdk & endocrine therapy in er /her2- metastatic breast cancer
-
8:39
secretomes from metastatic breast cancer cells and msc actions | oncotarget
-
1:39
dr. tolaney on novel approaches in treating her2-positive breast cancer
-
7:30
#esmo21 expert video report on her2-positive metastatic breast cancer